Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide
Craig W. Freyer(Hospital of the University of Pennsylvania), Alison W. Loren(University of Pennsylvania), Daria V. Babushok(Hospital of the University of Pennsylvania), Selina M. Luger(University of Pennsylvania), Shannon Gier(University of Pennsylvania), James K. Mangan(UC San Diego Health System), Mindy G. Schuster(Unknown), Edward A. Stadtmauer(University of Pennsylvania), Alexander E. Perl(University of Pennsylvania), Saar Gill(Parker Institute for Cancer Immunotherapy), Jacqueline Smith(Roslin Institute), Keith W. Pratz(University of Pennsylvania), Shannon R. McCurdy(Hospital of the University of Pennsylvania), Colleen Timlin(Hospital of the University of Pennsylvania), Alison Carulli(Hospital of the University of Pennsylvania), Noelle V. Frey(Hospital of the University of Pennsylvania), Elizabeth O. Hexner(University of Pennsylvania), Alex Ganetsky(Hospital of the University of Pennsylvania), David Porter(University of Pennsylvania), Mary Ellen Martin(University of Pennsylvania)
Cited by 10
Related Papers
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2015|4k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)
|Clinical Infectious Diseases|2010|1.5k